The advent of new biologic medicines in the past 25 years has been transformational, introducing powerful new treatments for a range of autoimmune disorders. But these drugs don’t help all patients ...

Candid's Series D round was led by Sixth Street Growth, with participation from Oak HC/FT, 8VC and Y Combinator.

VBC aligns reimbursements to outcomes, emphasizing the quality and effectiveness, not quantity, of healthcare activities. But ...

The question is no longer whether healthcare innovation is accelerating. The question is where investors gain access to ...

Headspace, a mental health company, announced on Tuesday that it is expanding its specialty care ecosystem with partnerships ...

Assured Health raised $19 million for its AI agents that verify provider credentials and manage insurance enrollment for ...

Health tech investors say the founders who win them over aren't the ones with all the answers, but the ones who know exactly ...

Drug spending continues to grow, but that doesn’t mean that everyone is getting the medicines that they need. A panel at ...

For many people, managing a disease means chronic therapy. Scribe Therapeutics has a different vision: genetic medicines that offer durable effects for the masses. With its lead program on a path to ...

These three legal regimes are pulling in different directions, and the developers that navigate them well will be the ones ...